Top Markets
Coin of the day
Arch Therapeutics, Inc. Arch Therapeutics, Inc.

Arch Therapeutics, Inc.

ARTH
株式のランク #42478
Arch Therapeutics, Inc., operating alongside its affiliated companies,... Arch Therapeutics, Inc., operating alongside its affiliated companies, functions as a biotechnology firm within the United States. The organization focuses on developing and commercializing products derived from its unique AC5 self-assembling technology platform. These innovations are engineered to arrest bleeding, control fluid leakage, and assist in wound care during surgical interventions, following trauma, throughout interventional medical procedures, or in cases of disease. Its leading products, the AC5 advanced wound system and the AC5 topical hemostat, are specifically designed for application on the skin, proving effective for managing intricate chronic wounds or acute surgical injuries. The company was established in 2006 and is headquartered in Framingham, Massachusetts.
株価
$0.0009
最終同期: 2025-05-27
時価総額
$1.15K
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Arch Therapeutics, Inc. (ARTH)

カテゴリー

Arch Therapeutics, Inc.(ARTH)の営業利益率
August 2026 時点の営業利益率 TTM: -6,661.67%
Arch Therapeutics, Inc. の最新の財務報告と株価によると、現在の営業利益率(TTM)は -6,661.67% です。2022 年末時点では -36,473.33% でした。
Arch Therapeutics, Inc. の営業利益率の履歴(2011 から 2026)
各年末の営業利益率
営業利益率 変化
2026 (TTM) -6,661.67% 0.00%
2023 -6,661.67% -81.74%
2022 -36,473.33% -33.86%
2021 -55,141.58% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
2018 0.00% 0.00%
2017 0.00% 0.00%
2016 0.00% 0.00%
2015 0.00% 0.00%
2014 0.00% 0.00%
2013 0.00% 0.00%
2012 0.00% 0.00%
2011 0.00% 0.00%
同業他社の営業利益率
企業 営業利益率 営業利益率の差
38.97% -100.01%
US
28.81% -100.00%
NL
0.00% -
CH
31.23% -100.00%
BE
0.00% -
KR
企業の営業利益率とは?
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。